PLAY PODCASTS
How Cleerly and HeartFlow are hunting a massive, but still elusive killer – heart disease

How Cleerly and HeartFlow are hunting a massive, but still elusive killer – heart disease

Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vice president and chief medical officer of HeartFlow, who will explain how the company’s HeartFlow FFRCT Analysis tool can bring new data to bear. Then, we’ll connect with James Min, MD, co-founder and CEO of Cleerly, a start-up employing artificial intelligence and other tools that he says will help dispel the mystery of this elusive killer.

DeviceTalks Podcast Network · DeviceTalks Podcast Network

September 10, 202248m 25s

Audio is streamed directly from the publisher (episodes.castos.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vice president and chief medical officer of HeartFlow, who will explain how the company’s HeartFlow FFRCT Analysis tool can bring new data to bear. Then, we’ll connect with James Min, MD, co-founder and CEO of Cleerly, a start-up employing artificial intelligence and other tools that he says will help dispel the mystery of this elusive killer.
← All episodes of DeviceTalks Podcast Network